Option Care Selected as the Home and Alternate Site Infusion Provider for Newly Approved Breakthrough Therapy, TrogarzoTM (ibalizumab-uiyk) Injection
BANNOCKBURN, Ill., March 9, 2018 – Option Care Enterprises, Inc., the nation’s largest independent provider of home and alternate treatment site [...]